ArticleCell reports. Medicine2020
CD103
Open access · goldAbstract read
In one paragraph
Article in Cell reports. Medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 126 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
126citing papers in PubMed, 1 pooled it
6.0field-weighted citation impact, top 3% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
126 citing papers in PubMed, 1 synthesis or guideline pooled it, 188 citations in OpenAlex.
- Comparison of different predictive biomarker testing assays for PD-1/PD-L1 checkpoint inhibitors response: a systematic review and network meta-analysis.Frontiers in immunology · 2023Pooled it
- From cell counts to cellular interactions: Cu-Cyto and the co-localization index as a spatial framework for the tumor immune microenvironment of rectal cancer.International journal of clinical oncology · 2026Review
- Autophagy Orchestrates Anti-Tumor Immunity to Enhance Chemosensitivity via the FBXW2/C/EBPβ/TIMP-2 Axis in Colorectal Cancer.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- PRDM15 inhibits responses of Tissue-Resident memory T cells by activating PVR/TIGIT axis to mediate gastric cancer immunosuppression.Journal of advanced research · 2026Article
- CD8MedComm · 2026Review
- Article
- Immunological mechanism behind reactivated cryptococcosis in persistently infected mice following FTY720 treatment.Infection and immunity · 2026Article
- Spatial single-cell proteotyping reveals immunotherapy-resistant features within the complex tumor microenvironment of metastatic NSCLC.The Journal of clinical investigation · 2026Article
- E-cadherin inactivation shapes tumor microenvironment specificities in invasive lobular breast cancer.Nature communications · 2026Article
- Contextualizing TNature reviews. Immunology · 2026Review
- Higher proximity of PD-L1Translational lung cancer research · 2026Article
- The Proximity of PD-1Cancers · 2026Article
- Cancer Stem Cells Shift Metabolite Acetyl-Coenzyme A to Abrogate the Differentiation of CD103Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- CD4 and CD8 T-cell lymphocytes from penile squamous cell carcinoma tumors are more differentiated with higher PD-1 expression compared to lymphocytes in peripheral circulation.Immunology letters · 2026Review
- Tissue-resident memory T cells reshapeFrontiers in immunology · 2026Review
- The Janus face of tissue-resident memory T cells: dual programming in tumor immune surveillance and autoimmune pathology.Frontiers in immunology · 2026Review
- JAK inhibition in PD-1 immunotherapy and tumor microenvironment.Frontiers in immunology · 2026Review
- Distribution and function of human long-lasting T cells in aging and non-small cell lung cancer.Frontiers in immunology · 2026Review
- Antigen reactivity defines tissue-resident memory and exhausted T cells in tumors.Nature immunology · 2026Article
- Comparative analysis of malignant pleural effusion and peripheral blood reveals unique T cell signatures associated with survival in mesothelioma patients.Oxford open immunology · 2026Article
66 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors at 8 institutions in 1 country.
Stéphanie CorgnacINSERM UMR 1186, Integrative Tumor Immunology and Immunotherapy, Gustave Roussy, Faculté de Médecine, Université Paris-Sud, Université Paris-Saclay, 94805 Villejuif, France.
Ines MalenicaINSERM UMR 1186, Integrative Tumor Immunology and Immunotherapy, Gustave Roussy, Faculté de Médecine, Université Paris-Sud, Université Paris-Saclay, 94805 Villejuif, France.
Laura MezquitaDepartment of Cancer Medicine, Gustave Roussy, Institut d'Oncologie Thoracique, Gustave Roussy, Université Paris-Saclay, 94805 Villejuif, France.
Edouard AuclinGastrointestinal and Medical Oncology Department, Hôpital Européen Georges Pompidou, Paris, France.
Elodie VoilinINSERM UMR 1186, Integrative Tumor Immunology and Immunotherapy, Gustave Roussy, Faculté de Médecine, Université Paris-Sud, Université Paris-Saclay, 94805 Villejuif, France.
Jamila KacherINSERM UMR 1186, Integrative Tumor Immunology and Immunotherapy, Gustave Roussy, Faculté de Médecine, Université Paris-Sud, Université Paris-Saclay, 94805 Villejuif, France.
Heloise HalseINSERM UMR 1186, Integrative Tumor Immunology and Immunotherapy, Gustave Roussy, Faculté de Médecine, Université Paris-Sud, Université Paris-Saclay, 94805 Villejuif, France.
Laetitia GrynszpanINSERM UMR 1186, Integrative Tumor Immunology and Immunotherapy, Gustave Roussy, Faculté de Médecine, Université Paris-Sud, Université Paris-Saclay, 94805 Villejuif, France.
Nicolas SignolleINSERM Unit U981, Department of Experimental Pathology, Gustave Roussy, Université Paris-Sud, Université Paris-Saclay, 94805 Villejuif, France.
Thibault DayrisDepartment of Biology and Medical Pathology, Gustave Roussy, 94805 Villejuif, France.
Marine LeclercINSERM UMR 1186, Integrative Tumor Immunology and Immunotherapy, Gustave Roussy, Faculté de Médecine, Université Paris-Sud, Université Paris-Saclay, 94805 Villejuif, France.
Nathalie DroinDepartment of Biology and Medical Pathology, Gustave Roussy, 94805 Villejuif, France.
Vincent de MontprévilleINSERM UMR 1186, Integrative Tumor Immunology and Immunotherapy, Gustave Roussy, Faculté de Médecine, Université Paris-Sud, Université Paris-Saclay, 94805 Villejuif, France.
Olaf MercierHôpital Marie-Lannelongue, Service d'Anatomie Pathologique, 92350 Le-Plessis-Robinson, France.
Pierre ValidireInstitut Mutualiste Montsouris, Service d'Anatomie Pathologique, 75014 Paris, France.
Jean-Yves ScoazecDepartment of Biology and Medical Pathology, Gustave Roussy, 94805 Villejuif, France.
Christophe MassardDrug Development Department, Gustave Roussy, Université Paris-Saclay, 94805 Villejuif, France.
Salem ChouaibINSERM UMR 1186, Integrative Tumor Immunology and Immunotherapy, Gustave Roussy, Faculté de Médecine, Université Paris-Sud, Université Paris-Saclay, 94805 Villejuif, France.
David PlanchardDepartment of Cancer Medicine, Gustave Roussy, Institut d'Oncologie Thoracique, Gustave Roussy, Université Paris-Saclay, 94805 Villejuif, France.
Julien AdamINSERM UMR 1186, Integrative Tumor Immunology and Immunotherapy, Gustave Roussy, Faculté de Médecine, Université Paris-Sud, Université Paris-Saclay, 94805 Villejuif, France.
Benjamin BesseDepartment of Cancer Medicine, Gustave Roussy, Institut d'Oncologie Thoracique, Gustave Roussy, Université Paris-Saclay, 94805 Villejuif, France.
Fathia Mami-ChouaibINSERM UMR 1186, Integrative Tumor Immunology and Immunotherapy, Gustave Roussy, Faculté de Médecine, Université Paris-Sud, Université Paris-Saclay, 94805 Villejuif, France.
Institut Gustave Roussy · FRUniversité Paris-Saclay · FRInserm · FRLaboratoire d’immunologie intégrative du cancer · FRUniversité Paris-Sud · FRHôpital Européen Georges-Pompidou · FRHôpital Marie Lannelongue · FRInstitute Mutualiste Montsouris · FR
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accumulation of CD103
Indexed as
Antigens, CDAntineoplastic Agents, ImmunologicalB7-H1 AntigenCarcinoma, Non-Small-Cell LungCD8 AntigensCD8-Positive T-LymphocytesCytotoxicity, ImmunologicGene Expression RegulationHumansIkaros Transcription FactorImmunologic MemoryImmunotherapyIntegrin alpha ChainsInterleukin-17Lung NeoplasmsLymphocyte Activationalpha E integrinsAntigens, CDAntineoplastic Agents, ImmunologicalB7-H1 AntigenCD274 protein, humanCD8 AntigensIkaros Transcription FactorIKZF3 protein, humanIntegrin alpha ChainsInterleukin-17PDCD1 protein, humanProgrammed Cell Death 1 ReceptorSTAT3 protein, humanSTAT3 Transcription FactorAiolos, AhR, and T-bet transcription factorsanti-PD-1 immunotherapyCD103 integrinCD8 TRM cellsCTLICB response biomarkerslung cancerTc17TCR repertoiretumor-infiltrating lymphocytes
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.